Literature DB >> 31152881

Spinal Myxopapillary Ependymoma: The Sapienza University Experience and Comprehensive Literature Review Concerning the Clinical Course of 1602 Patients.

Alessandro Pesce1, Mauro Palmieri2, Daniele Armocida3, Alessandro Frati4, Massimo Miscusi5, Antonino Raco2.   

Abstract

BACKGROUND: Spinal myxopapillary ependymoma (sMPE) is an uncommon primary spinal neoplasm infiltrating the spinal cord, conus medullaris (CM), and nerve roots. It is associated with low resection and high recurrence rates. The purpose of this literature review is to evaluate the exact impact of the involvement of the CM and the role played by gross total resection (GTR) on overall survival (OS).
METHODS: The English literature was systematically investigated using MEDLINE, the NIH Library, PubMed, and Google Scholar search engines with relevant queries. Case series reporting details concerning OS, GTR, and CM involvement rate were included, with a differential statistical weight given by the number of patients enrolled. A final cohort of 1602 clinical records was analyzed according to the 3 selected end point variables.
RESULTS: The average age was 36.44 ± 3.41 years, and the CM was involved in 28.4% ± 28.2% of cases. The average GTR rate was 53.94% ± 22.20%. Five- and 10-year OS rates were respectively available in 1170 and 1167 cases, with an average 5- and 10-year OS rate of 94.99% ± 3.87% and 92.31% ± 5.73%. By means of analyses performed both on aggregated and disaggregated data a strong positive statistical connection between GTR and increased OS was demonstrated despite the real clinical advantage could range as low as around 1% of increased OS rate.
CONCLUSIONS: Given the indolent sMPE behavior, it is difficult to evaluate the exact impact of GTR and CM involvement on OS; however, GTR could be associated with a limited survival advantage, whereas CM involvement could be associated with a survival disadvantage.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Conus medullaris; MRI; Spinal cord; Spinal myxopapillary ependymoma; Tumors

Mesh:

Year:  2019        PMID: 31152881     DOI: 10.1016/j.wneu.2019.05.206

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  EGFR amplification is a real independent prognostic impact factor between young adults and adults over 45yo with wild-type glioblastoma?

Authors:  Daniele Armocida; Alessandro Pesce; Alessandro Frati; Antonio Santoro; Maurizio Salvati
Journal:  J Neurooncol       Date:  2019-12-30       Impact factor: 4.130

2.  Clinical characteristics and long-term surgical outcome of spinal myxopapillary ependymoma: a French cohort of 101 patients.

Authors:  Anne-Sophie Montero; Suzanne Tran; Aymeric Amelot; Félix Berriat; Guillaume Lot; Stephan Gaillard; Chiara Villa; Marc Polivka; Clovis Adam; Ahmed Idbaih; Loïc Feuvret; Alexandre Carpentier; Fabrice Parker; Franck Bielle; Bertrand Mathon
Journal:  J Neurooncol       Date:  2021-02-23       Impact factor: 4.130

Review 3.  MYXOPAPILLARY EPENDYMOMA OF THE SPINAL CORD IN ADULTS: A REPORT OF PERSONAL SERIES AND REVIEW OF LITERATURE.

Authors:  Ibrahim Omerhodžić; Mirza Pojskić; Krešimir Rotim; Bruno Splavski; Lukas Rasulić; Kenan I Arnautovic
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.